Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
Anti-HIV I(0), II/p24 (Human) ELISA Kit
Anti-Infliximab (Human) ELISA Kit (Semi-Quantitative)
Anti-Infliximab Biosimilar (Human) ELISA Kit (Semi-Quantitative)
Anti-insulin asparte (Human) ELISA Kit
Anti-Ipilimumab (Human) ELISA Kit (Qualitative)
Anti-Ipilimumab (Human) ELISA Kit (Quantitative)
Anti-Ixekizumab (Human) ELISA Kit (Qualitative)
Anti-Natalizumab (Human) ELISA Kit (Qualitative)
Anti-Natalizumab (Human) ELISA Kit (Quantitative)
Anti-Nivolumab (Human) ELISA Kit (Qualitative)
Anti-Nivolumab (Human) ELISA Kit (Quantitative)